Norway Multiomics Market Size & Outlook, 2025-2033
Related Markets
Norway multiomics market highlights
- The Norway multiomics market generated a revenue of USD 7.3 million in 2024 and is expected to reach USD 15.4 million by 2033.
- The Norway market is expected to grow at a CAGR of 8.6% from 2025 to 2033.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2024 | USD 7.3 million |
| Market revenue in 2033 | USD 15.4 million |
| Growth rate | 8.6% (CAGR from 2025 to 2033) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, Norway accounted for 0.3% of the global multiomics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK multiomics market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,008.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | https://www.genomics.cn/ |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Bruker Corp | View profile | 9707 | 40 Manning Road, Billerica, MA, United States, 01821 | https://www.bruker.com |
| Revvity Inc | View profile | 11500 | 940 Winter Street, Waltham, MA, United States, 02451 | https://www.revvity.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Shimadzu Corp | View profile | 15284 | 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan, 604-8511 | http://www.shimadzu.com |
Norway multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 64.38% in 2024. Horizon Databook has segmented the Norway multiomics market based on services, product covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing funding related to gene therapy in the country is expected to create growth opportunities for market growth. For instance, in December 2022, Haapaniemi group approved around USD 2 million (NOK 20 million) to develop a clinical trial with genome-edited T cells.
This initiative aims to develop Tcell therapy for STwAT1 Gain-of-Function disorder and other immunodeficiencies. On the other hand, the Norwegian government recognized the importance of multiomics research and provided support through funding and initiatives aimed at promoting scientific research & innovation.
For instance, the Clinical and Multi-omic (CAMO) cohort, a part of the Norwegian Women and Cancer (NOWAC) study performed in February 2023, involved collecting comprehensive epidemiological and clinical information, along with blood and tumor samples, to establish a cohort conducive to integrated research approaches.
Reasons to subscribe to Norway multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Norway multiomics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Norway multiomics market size, by product & service, 2021-2033 (US$M)
Norway Multiomics Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
